Stimcell Energetics (STME) Shareholder's Equity Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Stimcell Energetics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 10.03% |
| Nov 30, 2025 | 11.16% |
| Aug 31, 2025 | 12.83% |
| May 31, 2025 | 14.71% |
| Feb 28, 2025 | 16.52% |
| Nov 30, 2024 | 16.84% |
| Aug 31, 2024 | 16.38% |
| May 31, 2024 | 19.36% |
| Feb 29, 2024 | 27.84% |
| Nov 30, 2023 | -14.47% |
| Aug 31, 2023 | -18.45% |
| May 31, 2023 | -16.20% |
| Feb 28, 2023 | -16.26% |
| Nov 30, 2022 | -51.81% |
| Aug 31, 2022 | -56.15% |
| May 31, 2022 | -4.26% |
| Feb 28, 2022 | -3.94% |
| Nov 30, 2021 | -5.94% |
| Aug 31, 2021 | -5.70% |
| May 31, 2021 | -13.66% |
| Feb 28, 2021 | -31.10% |
| Nov 30, 2020 | -40.64% |
| Aug 31, 2020 | -12.99% |
| May 31, 2020 | -9.14% |
| Feb 29, 2020 | -23.87% |
| Nov 30, 2019 | 70.14% |
| Aug 31, 2019 | 39.40% |
| May 31, 2019 | -7.86% |
| Feb 28, 2019 | -10.92% |
| May 31, 2017 | -285.60% |
| May 31, 2016 | -811.05% |
| Feb 29, 2016 | -1,383.17% |
| May 31, 2014 | -82.18% |